Therapy of Nephrology and Hypertension: A Companion to Brenner and Rector 2/e

Part I: General Principles of Clinical Trials
1. Clinical Trials in Nephrology and Hypertension

Part II: Acute Renal Failure (ARF)
2. Management of ARF
3. Use of Crystalloids and Colloids
4. Dopamine Therapy
5. Contrast Nephropathy
6. Hepatorenal Syndrome
7. Peritoneal Dialysis
8. Continuous Dialysis Treatment of ARF
9. Nutritional Management of ARF
10. Experimental Strategies for ARF-The Future

Part III: Diseases of Glomeruli, Microvasculature, and
Tubulointerstitium
11. Renal Biopsy as a Guide to the Treatment of
Glomerulonephritis
12. Immunosuppressive Therapy in Immunologic Renal Disease and
Transplantation
13. Fish Oils and Other Dietary Treatments of the Inflammatory
Response
14. Plasmapheresis
15. Infection-Associated Glomerulonephritis
16. Cryoglobulinemia
17. Lupus Nephritis
18. IgA Nephropathy and Henoch-Schonlein Purpura
19. Rapidly Progressive Glomerulonephritis
20. ANCA-Associated and Other Renal Vasculitides
21. Minimal Change Disease
22. Primary Focal Segmental Glomerulosclerosis
23. Idiopathic Membranous Nephropathy
24. Idiopathic Membranoproliferative Glomerulonephritis
25. Amyloid, Fibrilliary and other Glomerular Deposition
Diseases
26. Hepatitis-and HIV-Related Renal Diseases
27. Management of Complications of Nephrotic Syndrome
28. Thrombotic Microangiopathies
29. Acute Interstitial Nephritis
30. New Horizons in the Treatment of Glomerulonephritis
31. Functional genomes: Prospects for New Treatments in
Nephrology and Hypertension

Part IV: Diabetic Nephrothy
32. Prevention and Management of Diabetic Nephropathy
33. Management of the Diabetic Patient with Renal Disease

Part V: Disorders of Fluid, Electrolyte, and Acid Based
Homeostasis
34. Dysnatremic Disorders
35. Potassium Disorders
36. Metabolic Acidosis
37. Metabolic Alkalosis
38. Hypercalcemia and Other Divalent Cation Disorders

Part VI: Nephrolothiasis
39. Nephrolothiasis
40. Nephrolithiasis: Lithotripsy and Surgery

Part VII: Genitourinary Infections, Malignancy and Obstruction
41. Urinary Tract Infections
42. Primary Neoplasms of the Kidney
43. Myeloma and Secondary Involvement of the Kidney in
Neoplastic Diseases
44. Urinary Tract Infections and Obstruction

Part VIII: Renal Disease and Pregnancy
45. Hypertension in Pregnancy
46. Management of Renal Disease in Pregnancy
47. Erectile Dysfunction in ESRD

Part IX: Inherited Renal Disease
48. Renal Cystic Disorders
49. Non-Cystic Hereditary Diseases of the Kidney
50. Prospects for Gene Therapy

Part X: Management of Essential Hypertension
51. Targets and Decisions for Hypertension Treatment
52. Nonpharmacologic Treatment
53. Diuretics and Beta-Blockers
54. ACEIs, ARBs and aldosterone antagonists
55. Calcium Antagonist
56. Individualization of Pharmacologic Therapy
57. Control of CVS Risk Factors in Hypertension
58. Hypertensive urgencies and Emergencies

Part XI: Management of Secondary Hypertension
59. Renovascular Hypertension & Ischemic Nephropathy: Medical
Management
60. Renovascular Hypertension & Ischemic Nephropathy:
Angioplasty and Stenting
61. Renovascular Hypertension & Ischemic Nephropathy: Surgical
Treatment
62. Hypertension in Renal Transplant Recipients
63. Hypertension in Patients Receiving Dialysis Therapy
64. Hypertensive Adrenal Disorders

Part XII: Chronic Renal Failure and Its Systemic Manifestations
65. Prevention of Progressive Renal Failure
66. Dyslipidemia
67. Hyperhomocysteinemia
68. Oxidative Stress
69. Nutritional Therapy
70. Iron and Erythropoietin-Related Therapies
71. Coagulopathy
72. Neuropsychiatric Complications
73. Calcium, Phosphorus and Bone Disease
74. Cardiovascular Complications
75. Erectile Dysfunction

Part XIII: Maintenance Dialysis
76. Technical aspects of Hemodialysis
77. Choice and Maintenance of Vascular Access
78. Hemodialysis Adequacy
79.